MORRISTOWN, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, will host investor meetings at two upcoming conferences:
- Brean Capital 2015 Life Sciences Summit on November 16, 2015 at the Millennium Broadway Hotel in New York City.
- Jefferies Autumn 2015 Global Healthcare Conference, November 18-19, 2015 at The May Fair Hotel in London.
About Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
To learn more about Pernix Therapeutics, visit www.pernixtx.com.
Investor Relations Sanjay Patel, (800) 793-2145 ext. 1009 Chief Financial Officer firstname.lastname@example.org Lisa Wilson, 212-452-2793 In-Site Communications email@example.com Media Relations Marianne Lambertson, (800) 793-2145 ext. 1012 Vice President, Strategic Development firstname.lastname@example.org
Source:Pernix Therapeutics Holdings, Inc.